Literature DB >> 15046208

In vitro acid exposure has a differential effect on apoptotic and proliferative pathways in a Barrett's adenocarcinoma cell line.

Claire Morgan1, William Alazawi, Pierre Sirieix, Tom Freeman, Nicholas Coleman, Rebecca Fitzgerald.   

Abstract

INTRODUCTION: Acid, a principal component of refluxate, may contribute to the neoplastic progression of Barrett's esophagus. Brief acid exposure in vivo and in vitro has been shown to increase cell proliferation. The mechanisms underlying the hyperproliferative response are not well elucidated but may include alterations in Na(+)-H+ exchanger activity and MAPK signaling pathways.
OBJECTIVE: To ascertain the effects of pulsatile acid exposure on gene expression in a Barrett's adenocarcinoma cell line (SEG-1).
METHODS: SEG-1 cells were exposed to either acidified DMEM at pH 3.5 (0.1 M hydrochloric acid) or pH 7.4 (control) for 20 min followed by neutralization of the medium. Total RNA was extracted before acid exposure and over a 10-h time course (0.5, 2, 4, 6, 8, and 10 hours) and hybridized to Affymetrix human U133A oligonucleotide arrays. Data were analyzed using the Affymetrix statistical expression algorithms. Only alterations in gene expression that were > or = 2 and < or = -2 fold were studied further and a subset was further investigated by reverse transcription polymerase chain reaction (RT-PCR) and densitometry. Apoptosis was assayed in SEG-1 cells by western blot for cleaved caspase 3 and an apoptosis ELISA assay.
RESULTS: Changes in expression were identified for 138 genes. Analysis of gene function identified immediate downregulation of genes associated with apoptosis and early upregulation of genes associated with proliferation. The gene expression profiles suggest that MAPK pathways may be involved and suppression of apoptosis may occur via p53-dependent mechanisms.
CONCLUSIONS: Microarray analysis of gene expression changes in a Barrett's adenocarcinoma cell line has identified cellular pathways that may be disrupted following acid exposure.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15046208     DOI: 10.1111/j.1572-0241.2004.04054.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  13 in total

1.  Chemoprevention of esophageal adenocarcinoma.

Authors:  Julian A Abrams
Journal:  Therap Adv Gastroenterol       Date:  2008-07       Impact factor: 4.409

2.  CDX1 is an important molecular mediator of Barrett's metaplasia.

Authors:  N A C S Wong; J Wilding; S Bartlett; Y Liu; B F Warren; J Piris; N Maynard; R Marshall; W F Bodmer
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-13       Impact factor: 11.205

Review 3.  Barrett's oesophagus and oesophageal adenocarcinoma: how does acid interfere with cell proliferation and differentiation?

Authors:  R C Fitzgerald
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

4.  Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett's oesophagus.

Authors:  Katerina Dvorak; Claire M Payne; Melissa Chavarria; Lois Ramsey; Barbora Dvorakova; Harris Bernstein; Hana Holubec; Richard E Sampliner; Naihsuan Guy; Amanda Condon; Carol Bernstein; Sylvan B Green; Anil Prasad; Harinder S Garewal
Journal:  Gut       Date:  2006-12-04       Impact factor: 23.059

5.  Interactions between genetic polymorphisms in the apoptotic pathway and environmental factors on esophageal adenocarcinoma risk.

Authors:  I-Chen Wu; Yang Zhao; Rihong Zhai; Chen-yu Liu; Feng Chen; Monica Ter-Minassian; Kofi Asomaning; Li Su; Rebecca S Heist; Matthew H Kulke; Geoffrey Liu; David C Christiani
Journal:  Carcinogenesis       Date:  2011-01-06       Impact factor: 4.944

6.  Transformation of benign Barrett's epithelium by repeated acid and bile exposure over 65 weeks: a novel in vitro model.

Authors:  Kiron M Das; Yingxin Kong; Manisha Bajpai; Diptee Kulkarni; Xin Geng; Pravin Mishra; Debabrata Banerjee; Kim Hirshfield
Journal:  Int J Cancer       Date:  2010-03-22       Impact factor: 7.396

7.  Elevated serum gastrin is associated with a history of advanced neoplasia in Barrett's esophagus.

Authors:  Judy S Wang; Andrea Varro; Charles J Lightdale; Nantaporn Lertkowit; Kristen N Slack; Michael L Fingerhood; Wei Yann Tsai; Timothy C Wang; Julian A Abrams
Journal:  Am J Gastroenterol       Date:  2009-11-10       Impact factor: 10.864

8.  Verification and unmasking of widely used human esophageal adenocarcinoma cell lines.

Authors:  Jurjen J Boonstra; Ronald van Marion; David G Beer; Lin Lin; Paula Chaves; Catarina Ribeiro; A Dias Pereira; Lúcia Roque; S Jane Darnton; Nasser K Altorki; David S Schrump; David S Klimstra; Laura H Tang; James R Eshleman; Hector Alvarez; Yutaka Shimada; Herman van Dekken; Hugo W Tilanus; Winand N M Dinjens
Journal:  J Natl Cancer Inst       Date:  2010-01-14       Impact factor: 13.506

Review 9.  Molecular basis of Barrett's oesophagus and oesophageal adenocarcinoma.

Authors:  R C Fitzgerald
Journal:  Gut       Date:  2006-12       Impact factor: 23.059

Review 10.  Cell culture models for studying the development of Barrett's esophagus: a systematic review.

Authors:  P Bus; P D Siersema; J W P M van Baal
Journal:  Cell Oncol (Dordr)       Date:  2012-04-03       Impact factor: 6.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.